Accelerating time to market: Platform-based solutions to get you to IND/IMPD faster

Now more than ever, you’re asked to do more in less time. Alessandro Chreim, Global Subject Matter Expert, Steriles, Thermo Fisher Scientific, will share key market trends and drug development challenges that are facing us today, globally. Alessandro will give an overview of Thermo Fisher’s  Quick to Clinic™ program – a speed-focused solution, built for small and large molecule drug development as well as viral vector services. Speed doesn’t mean opening yourself up to risk. Using a tried and tested process platform backed by supply assurance from a company with broad expertise means you don’t have to sacrifice quality for speed. Quick to Clinic™ is designed to accelerate early development, ensuring that critical details aren’t overlooked. Alessandro will share information on Thermo Fisher’s capabilities and expertise, and how we have helped new and emerging biotechs to balance speed, risk and future needs during early development to get to IND/IMPD faster.


Alessandro Chreim

Alessandro Chreim

Thermo Fisher Scientific